The Neural Cell Adhesion Molecule L1 Potentiates Integrin-Dependent Cell Migration to Extracellular Matrix Proteins by Thelen, Karsten et al.
The Neural Cell Adhesion Molecule L1 Potentiates Integrin-
Dependent Cell Migration to Extracellular Matrix Proteins
Karsten Thelen,* Vishram Kedar,* Anitha K. Panicker,* Ralf-Steffen Schmid, Bentley R. Midkiff, and
Patricia F. Maness
Department of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, North Carolina
27599-7260
The L1 adhesion molecule regulates axon growth and is mu-
tated in the X-linked mental retardation syndrome CRASH (ac-
ronym for corpus callosum agenesis, retardation, aphasia,
spastic paraplegia, hydrocephalus). A novel role for L1 as a
potentiator of neuronal cell migration to extracellular matrix
proteins through 1 integrins and intracellular signaling to
mitogen-activated protein (MAP) kinase was identified. L1 po-
tentiated haptotactic migration of B35 neuroblastoma cells to-
ward fibronectin, vitronectin, and laminin through the signaling
intermediates c-Src, phosphatidylinositol-3 kinase, and MAP
kinase. L1 potentiated migration toward fibronectin through
51 integrin in human embryonic kidney 293 cells and de-
pended on determinants of L1 endocytosis: dynamin I, c-Src,
and the AP2/clathrin binding site (Arg-Ser-Leu-Glu) in the neu-
ronal splice form of L1. L1 clustering on the cell surface en-
hanced the internalization of activated 1 integrins and L1 into
distinct endocytic vesicles. L1-potentiated migration, enhance-
ment of 1 integrin endocytosis, and activation of MAP kinase
were coordinately inhibited by mutation of an RGD sequence in
the sixth immunoglobulin-like domain of L1. Moreover, three
CRASH mutations in the L1 cytoplasmic domain (1194L,
S1224L, Y1229H), two of which interfere with ankyrin associa-
tion, inhibited L1-potentiated migration and MAP kinase acti-
vation. Function-blocking antibodies to L1 and 1 integrin re-
tarded the migration of 5-bromo-2-deoxyuridine-labeled
mouse cerebellar granule cells in slice cultures, underscoring
the potential physiological relevance of these findings. These
studies suggest that L1 functionally interacts with 1 integrins
to potentiate neuronal migration toward extracellular matrix
proteins through endocytosis and MAP kinase signaling, and
that impairment of this function by L1 cytoplasmic domain
mutations may contribute to neurological deficits in CRASH.
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The L1 cell adhesion molecule is an integral membrane protein
that promotes axon growth and guidance critical to nervous
system development (for review, see Schmid and Maness, 2001).
L1 belongs to a family of Ig-like cell recognition molecules in-
cluding L1, CHL1, NrCAM, NgCAM, neurofascin, and Drosoph-
ila neuroglian, which share common structural elements and the
ability to promote axon growth. The L1 gene (on chromosome
Xq28) is the target for mutations in the human mental retardation
syndrome CRASH (acronym for corpus callosum agenesis, retar-
dation, aphasia, spastic paraplegia, hydrocephalus) (Kenwrick et
al., 2000). L1 null mutant mice display aspects of the CRASH
phenotype including axon guidance errors in the corticospinal
tract and corpus callosum, cortical dendrite abnormalities, re-
duced numbers of hippocampal neurons, defects in spatial mem-
ory, and enlarged ventricles (Cohen et al., 1997; Dahme et al.,
1997; Fransen et al., 1998; Demyanenko et al., 1999).
The L1 extracellular region is composed of six Ig-like and five
fibronectin type III domains that engage in L1–L1 homophilic
binding and heterophilic interactions with other Ig-class cell rec-
ognition molecules including axonin 1/TAG1, F11/F3/contactin,
and NCAM (Kadmon et al., 1990; Kuhn et al., 1991; Brummen-
dorf et al., 1993). L1 has been shown to interact functionally with
some integrins, including the fibronectin receptor 51 and vi-
tronectin receptor v3, for adhesion or neurite growth on L1
substrates (Moos et al., 1988, Ruppert et al., 1995; Ebeling et al.,
1996; Montgomery et al., 1996; Felding-Habermann et al., 1997).
The L1 intracellular domain bears a binding site for the cytoskel-
etal linker protein ankyrin (Bennett and Chen, 2001) and a
neuron-specific sequence Arg-Ser-Leu-Glu (RSLE) arising from
alternative splicing, which together with a preceding tyrosine
residue, comprises a motif for axon targeting and clathrin- and
dynamin-mediated endocytosis (Kamiguchi and Lemmon, 1998;
Kamiguchi et al., 1998). Although originally identified as a neural
cell adhesion molecule, L1 is also expressed in Schwann cells,
melanocytes, hematopoietic cells of lymphoid and myelomono-
cytic lineages, and epithelial cells (Takeda et al., 1996; Pancook et
al., 1997; Kadmon et al., 1998; Nolte et al., 1999). Potential
involvement of L1 in tumor development and metastasis is fur-
ther suggested by its expression on many tumor cell lines includ-
ing neuroblastoma, melanoma, and carcinomas (Linnemann et
al., 1989; Reid and Hemperly, 1992; Pancook et al., 1997).
In addition to the known function of L1 in axon growth, there
is evidence that L1 can participate in the migration of neuronal
precursors. L1 is expressed in dopaminergic neuronal precursors
during their tangential migration on L1-positive fiber tracts
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(Ohyama et al., 1998), and their final location is altered in L1
knock-out mice (Demyanenko et al., 2001). L1 is also expressed
transiently in migrating neuronal precursors within the develop-
ing cerebellum and neocortex (Fushiki and Schachner, 1986;
Beasley and Stallcup, 1987; Chung et al., 1991; Demyanenko et
al., 1999), and function-blocking L1 antibodies have been shown
to perturb the inward migration of granule cell precursors in
cerebellar explant cultures (Lindner et al., 1986; Chuong et al.,
1987; Crossin et al., 1990). In addition, L1 can promote hapto-
tactic migration of several types of culture cells toward purified
L1 substrates (Montgomery et al., 1996; Gutwein et al., 2000).
L1 promotes neurite outgrowth in cell cultures through the
central signal integrator MAP kinase (Schaefer et al., 1999;
Schmid et al., 2000) by a pathway that includes the nonreceptor
tyrosine kinase c-Src (Ignelzi et al., 1994), phosphatidylinositol-3
(PI3) kinase, Rac1 GTPase (Schmid et al., 2000), and the guanine
nucleotide exchange factor Vav-2 (R.-S. Schmid and P. F. Maness,
unpublished results). This pathway is closely related to an early-
acting signaling pathway induced by integrin activation that pro-
motes membrane ruffling, lamellipodia, and migration of non-
neural cells (Clark et al., 1998; Meng and Lowell, 1998; Miranti
et al., 1998). The common features of signaling by L1 and inte-
grins and evidence that L1 may participate in regulating neuronal
precursor migration lead us to speculate that L1 might interact
functionally with integrins to stimulate neuronal cell migration
on extracellular matrix molecules. In this study, we report a new
role for L1 as a potentiator of neuronal migration to extracellular
matrix proteins through 1 integrin and intracellular signaling
and show that CRASH mutations in the L1 cytoplasmic domain
impair this function.
MATERIALS AND METHODS
Reagents. Plasmids subcloned into pcDNA3 included human L1(/
RSLE) (John Hemperly, BD Technologies, Research Triangle Park,
NC), hemagglutinin (HA)-tagged extracellular signal regulated kinase
(ERK)2 (Melanie Cobb, University of Texas Southwestern Medical
School, Dallas, TX), dynamin I (K44A) (Marc Caron, Duke University,
Durham, NC), Src (K295M) (Sara Courtneidge, Sugen, San Francisco,
CA), and enhanced cyan fluorescence protein (Invitrogen, San Diego,
CA). All L1 mutants used here have been described in our previous work
(Needham et al., 2001). Mouse monoclonal antibody against human L1
(Neuro4) and anti-L1 polyclonal rabbit antibody 6096 were gifts of John
Hemperly (BD Technologies). The following antibodies were obtained
commercially: polyclonal anti-Active MAP kinase antibody (pTEpY)
(Promega, Madison, WI), antibody against MAP kinase protein (Santa
Cruz Biotechnology, Santa Cruz, CA), anti-human 1 integrin monoclo-
nal antibody (clone P4C10) against the RGD binding site (Invitrogen,
Gaithersburg, MD), anti-human 5 integrin (clone P1D6) against the
PHSRN synergy site (Invitrogen), anti-human v3 integrin monoclonal
antibody 1976Z (Chemicon, Temecula, CA), and monoclonal antibody
MAB 2000 that activates human 1 integrin (Chemicon). Human vitro-
nectin, human fibronectin, murine laminin, and peptides GRGDSP and
GRGESP were from Invitrogen or Peninsula laboratories; murine colla-
gen type IV was from Sigma (St. Louis, MO). Recombinant reelin
secreted from reelin-transfected human embryonic kidney (HEK) 293T
cells and control supernatant from untransfected cells were a gift from Eva
Anton (University of North Carolina, Chapel Hill, NC). The Src inhibitor
4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo[3,4-D]pyrimidine (PP2)
(Hanke et al., 1996) and inactive analog 4-amino-7-phenylpyra-
zolo[3,4-D]pyrimidine (PP3) were from Calbiochem (La Jolla, CA).
MAP kinase kinase (MEK) inhibitor U0126 (Promega), PI3 kinase
inhibitor Ly294002 (Calbiochem), PP2, and PP3 were dissolved in
dimethylsulfoxide (DMSO).
Cell culture procedures. Rat B35 neuroblastoma cell lines stably ex-
pressing human L1(RSLE) or L1 point mutants S1194L, S1224L, and
S1229H in pcDNA3 have been described (Needham et al., 2001). B35 cell
lines were maintained in DMEM, 10% fetal bovine serum, and genta-
mycin/kanamycin, 250 g/ml G418. HEK293 cells were maintained in
the same medium without G418 and transfected for transient expression
of pcDNA3 plasmids (10 g/100 mm dish) using lipofectamine with
transfection efficiency of 70% as described (Needham et al., 2001).
Haptotactic cell migration assay. Haptotactic cell migration assays were
performed in modified Boyden chambers (Transwells; Corning/Costar
3422) in serum-free DMEM containing 0.4 mM MnCl24H2O, 50 g/ml
gentamicin, and 200 g/ml kanamycin. Transwell chambers had polycar-
bonate filters with 8.0-m-diameter pores, the bottom sides of which
were coated with extracellular matrix proteins or bovine serum albumin
(BSA; fatty acid free, Sigma). Proteins in PBS were applied to the bottom
side of filters (3 g of protein per filter) and air dried. The bottom
surfaces of filters were washed and blocked in 2% BSA. Cells were
detached using PBS/Na-EDTA (5 mM) and 10,000–20,000 cells plated
per chamber. Some cells were preincubated with antibodies (2 g/100 l
medium) for 10 min at 4°C or peptides (2 mM) for 1 hr at 4°C in
serum-free medium.
To score B35 cells, cells from the top side of the filter were removed,
and cells on the bottom side of the filter were stained for 10–30 min with
Gill’s formula hematoxylin (Vector Laboratories, Burlingame, CA), and
at least 150 cells were scored within a 10  10 mm grid from nine or more
randomly selected fields using a 20 microscope objective. The mean
number of cells per field was multiplied by a factor based on the number
and size of fields scored and on a filter diameter of 6.5 mm to obtain the
total number of cells migrated. Experiments were performed in duplicate
or triplicate, and results were averaged. The means of experimental and
control samples and SEM were compared for significant differences using
Student’s t test. L1-expressing HEK293 cells were visualized by indirect
immunofluorescence staining with anti-L1 monoclonal antibody Neuro4
and FITC-labeled goat anti-mouse IgG and scored on both top and
bottom surfaces of filters under epifluorescence illumination. The per-
centage of L1-expressing cells that transmigrated was calculated by
determining the ratio of L1-positive cells on the bottom of the filter
compared with the total number of L1-positive cells on both sides of the
filter.
MAP kinase assay. B35 cells were transfected for transient expression
with HA-tagged ERK2 plasmid together with L1 plasmids, and phos-
phorylation of immunoprecipitated HA-ERK2 protein was measured by
Western blotting with anti-Active MAPK antibody against dually phos-
phorylated, activated ERKs as described (Schmid et al., 2000). At 36–40
hr after transfection, the medium was replaced with OptiMEM-I, and 8
hr later cells were treated with preformed complexes of either nonim-
mune mouse IgG or L1 antibody Neuro4 and F(ab)2 fragments of
secondary antibodies against Fc fragments of mouse IgG (Jackson Im-
munoResearch, West Grove, PA) for 10 min at 37°C. Cells were lysed in
buffer containing 1% NP-40, 0.25% Na-deoxycholate, 50 mM HEPES,
pH 7.4, 137 mM NaCl, 1 mM Na-EDTA, 10 mM phenylmethylsulfonyl
fluoride, 10 mM -glycerophosphate, 10 g/ml leupeptin, 0.1 TIU/ml
aprotinin, 1 g/ml pepstatin, 2 nM calyculin A, and 10% glycerol.
HA-tagged ERK2 was immunoprecipitated from lysates with anti-HA
antibody and protein G-Sepharose. Immune complexes were analyzed by
immunoblotting with anti-Active MAPK antibody using enhanced
chemiluminescence. Blots were stripped and reprobed with antibodies
against total ERK protein. Bands were quantified by densitometric scan-
ning, and levels of phosphorylated ERK2 were normalized to ERK2
protein. Each cell line was assayed in duplicate, and results were aver-
aged. L1-induced ERK2 phosphorylation was expressed as the fold-
activation relative to normal IgG control. Experiments were repeated
3–10 times, and mean ERK2 phosphorylation relative to normal IgG and
SEM was determined for each cell line. Some amount of nonspecific
ERK2 phosphorylation was elicited by nonimmune IgG in cells express-
ing mutant or wild-type L1, presumably attributable to binding of resid-
ual uncomplexed IgG to endogenous Fc receptors (Schmid et al., 2000),
but little variation in the normal IgG control was observed for each cell
line. Means for each L1 mutant or splice form were compared with
L1(RSLE), and significant differences were determined by the t test.
Immunofluorescence staining for endocytosis of L1 and 1 integrins.
HEK cells were plated at 20,000 cells per well onto LabTek II chamber
slides (Nunc, Naperville, IL) coated with poly-D-lysine (0.01%) and
human fibronectin (5 g/ml) and transfected with plasmid encoding
human L1(RSLE). After 16–18 hr cells were washed and incubated for
5–60 min at 37°C with polyclonal rabbit antibody 6096 against L1 (50
g/ml) and MAB2000, an activating monoclonal antibody against human
1 integrin (40 g/ml). Cells were fixed in 2% paraformaldehyde for 30
min and then permeabilized with 0.05% Triton X-100 in PBS, 10% goat
serum for 1 hr. Cells were incubated with FITC-conjugated goat anti-
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mouse IgG (750 g/ml) in PBS, 10% goat serum for 1 hr to label surface
and internalized integrins. After washing, cells were incubated with
tetramethylrhodamine isothiocyanate-conjugated goat anti-rabbit IgG
(750 g/ml) in PBS containing 10% goat serum for 30 min to label
surface and internalized L1. Slides were mounted with Vectashield, and
cells were analyzed using a Zeiss LSM10 confocal microscope with an
argon laser. Images of 0.5 m optical thickness through the middle of the
cells were captured at the University of North Carolina Microscopy
Services Facility, Department of Pathology (Dr. Robert Bagnell, Direc-
tor). L1 labeling was recorded using the 514 nm excitation filter with an
emission range of 575–645 nm. Integrin labeling was recorded using a
narrow band filter with 488 nm excitation range and 515–545 nm emission
range. NIH Image J software was used for pseudocolor. The mean
fluorescent pixel density of internalized integrins was measured in 18–28
randomly selected cells using Scion imaging for three experimental
groups: HEK293, L1(RSLE)-HEK293, and mutant L1(KGE)-
HEK293 cells treated for 5 min at 37°C with L1 and 1 integrin
antibodies as described above. The number of fluorescent pixels inside
each cell was measured and divided by the total number of pixels inside
the cell to obtain the fluorescent pixel density of each cell. The mean
fluorescent pixel density was calculated for all cells within each experi-
mental group. The mean fluorescent pixel densities of L1 and L1(KGE)-
expressing cells in three different experiments were normalized to the
corresponding mean fluorescent pixel densities of HEK293 cells (no L1)
in the same experiment and averaged (see Fig. 9). Significant differences
in means were determined by the t test (one-tailed; p  0.05).
Neuronal migration in cerebellar slices. Newly generated neurons were
labeled with 5-bromo-2-deoxyuridine (BrdU), and the extent of their
radial migration away from the external granular layer (EGL) was mea-
sured after 21 hr in culture. Mice (C57BL/6) at postnatal day 4 were
injected intraperitoneally with BrdU (10 mg/kg body weight) in saline
(Boehringer Mannheim, Indianapolis, IN). After 45 min brains were
removed, cerebella were dissected out, and 200 m coronal slices were
made. Adjacent slices were cultured on Millicell-CM 0.4 m membranes
(Millipore, Milford, MA) in MEM supplemented with 10% horse serum,
40 mM glucose, 1.8 mM glutamine, 24 mM Na-bicarbonate, and 90 U/ml
penicillin–streptomycin. In some samples, medium with adjacent sec-
tions of cerebellar slices from different mice was supplemented with
purified antibodies; rabbit polyclonal antibody 6096 against L1 (1 mg/ml),
hamster anti-rat CD29 monoclonal antibody against 1 integrin (0.1
mg/ml) (BD PharMingen), or nonimmune rabbit IgG (1.1 mg/ml). Slices
were removed at 0 or 21 hr of incubation in culture at 37°C in 5% CO2
and processed for BrdU by immunofluorescence staining. Slices were
fixed in 70% ethanol for 12 hr at 4°C. After three rinses in PBS, slices
were fixed in 2N HCl for 1 hr at room temperature, washed in PBS, and
incubated for 4 hr with BrdU monoclonal antibody (1:75 in PBS, 0.5%
Tween 20) for 4 hr (Becton Dickinson, Research Triangle Park, NC).
Slices were washed in PBS and incubated with anti-mouse IgG/M con-
jugated to Cy3 (1:100; Jackson ImmunoResearch) for 2 hr. Bis-
benzimide (10 M) was added 5 min before the end of the incubation.
Filters were rinsed in PBS, and slices were cut out and mounted onto
glass slides with Vectashield mounting medium. Slices were visualized
with a Zeiss confocal microscope using rhodamine or UV filter sets.
Images of 3 m optical sections were collected and stored on a CD and
then analyzed for cell migration using Scion Image software or assem-
bled into the panel of figures presented using Adobe Photoshop.
To determine the extent of migration of BrdU-labeled cells, the
shortest distance between the BrdU-labeled cells and the pial surface was
measured within at least four different slices at different locations, and
the average distance was calculated for at least 150 cells per experimental
condition. The average distance was then expressed relative to the
respective thickness of the cerebellar cortex within the same location
measured from bis-benzimide images to yield the migration index. Only
cells with brightly labeled nuclei were scored. Bis-benzimide labeling of
nuclei demarcated the different regions of the cerebellar cortex and white
matter. The location of the EGL, molecular layer (ML), and internal
granular layer (IGL) were confirmed by staining with hematoxylin-eosin.
After such demarcation, the number of BrdU-labeled cells within three
randomly selected regions of the cerebellar cortex from the pial surface
to the bottom of the IGL was compared with the number of labeled cells
within the EGL of the corresponding region for each experimental
condition to estimate the percentage of BrdU-labeled cells in the EGL.
Statistical differences between experimental groups was tested by Stu-
dent’s t test ( p  0.05; one-tailed).
RESULTS
L1 potentiates haptotactic cell migration to
extracellular matrix molecules through integrins
L1 signaling and endocytosis have been analyzed previously in
the CNS-derived B35 neuroblastoma cell line that stably ex-
presses the neuronal form of human L1(RSLE) (Schmid et al.,
2000; Needham et al., 2001). Haptotactic migration of
L1(RSLE)-B35 cells and parental B35 cells, which lack L1, was
studied in Transwell assays using modified Boyden chambers in
which cells migrated from top to bottom chambers through filters
coated on the bottom side with extracellular matrix protein.
Parental B35 neuroblastoma cells displayed greater migration in
16 hr toward fibronectin compared with their random migration
toward BSA (Fig. 1). Migration of L1(RSLE)-B35 cells toward
fibronectin was strongly stimulated (three- to fourfold) compared
with parental B35 cells. Migration of L1(RSLE)-B35 cells to-
ward laminin and vitronectin was also stimulated compared with
B35 cells not expressing L1. Neither B35 cells nor L1(RSLE)-
B35 cells displayed significant migration toward collagen type IV
or reelin, an extracellular matrix-like molecule that regulates
cortical neuron migration on radial glia (Dulabon et al., 2000).
The slight increase in migration of L1(RSLE)-B35 cells to
control and reelin-containing supernatants was probably caused
by small amounts of fibronectin in the conditioned medium.
To determine whether L1-potentiated migration to fibronectin
was mediated through an integrin-dependent mechanism,
HEK293 cells were used, because unlike B35 cells, they express
defined integrins for which function-blocking antibodies are
available. HEK293 cells express 51 integrin, which functions
as an RGD-dependent fibronectin receptor, and v1 integrin,
which functions as a fibronectin or vitronectin receptor (Bodary
and McLean, 1990), but they lack v3 or v5 integrins (Simon
et al., 1997) or L1 (Needham et al., 2001). HEK293 cells were
transfected for transient expression with a plasmid encoding
human L1(RSLE) or the control pcDNA3 plasmid, and hapto-
tactic migration was assayed toward fibronectin for 4 hr.
L1(RSLE)-HEK293 cells exhibited increased migration to fi-
bronectin compared with nonexpressing cells (Fig. 2). The migra-
tion of HEK293 cells after 4 hr was greater than that of B35 cells
after 16 hr. Treatment of L1-expressing cells with antibodies
against the extracellular region of L1 (anti-L1; Neuro4), at con-
centrations that did not induce clustering of L1, reduced migra-
Figure 1. L1 potentiates migration of B35 neuroblastoma cells to extra-
cellular matrix proteins. Haptotactic cell migration was measured in B35
cells (20,000 cells per chamber) expressing no L1 or L1(RSLE) toward
extracellular matrix proteins or BSA for 16 hr. Each sample was assayed
in triplicate, and experiments were repeated at least twice with similar
results.
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tion to the levels of untransfected cells, whereas an equivalent
amount of nonimmune IgG did not affect migration (Fig. 2).
Antibody P1D6 specific for the 5 integrin subunit (anti-5)
inhibited haptotactic migration of both L1-expressing and nonex-
pressing cells toward fibronectin (Fig. 2). This antibody maps to
the binding site for the fibronectin synergy sequence (PHSRN) in
5 integrin (Burrows et al., 1999). Antibody P4C10 against the 1
integrin RGD binding site also inhibited migration toward fi-
bronectin, as did a mixture of 5 and 1 integrin antibodies (Fig.
2). Monoclonal antibodies specific for v3 integrin had no effect
on migration. These results demonstrated that in the absence and
presence of L1, haptotactic migration toward fibronectin oc-
curred primarily through 51 integrins in HEK293 cells.
An RGD sequence within the cell binding domain of fibronec-
tin is the major binding site for 51 integrin. To investigate the
requirement for RGD binding in L1-potentiated migration to
fibronectin, HEK293 cells were preincubated with the RGD-
containing hexapeptide GRGDSP (2 mM) or an RGE-containing
control peptide GRGESP that does not bind to integrins and
assayed for haptotactic migration to fibronectin. Migration of
both L1-expressing and nonexpressing HEK293 cells was com-
pletely inhibited by RGD peptides but not by RGE peptides,
consistent with an 51 integrin mechanism (Fig. 3A). Haptotac-
tic migration of both L1-expressing and nonexpressing B35 neu-
roblastoma cells toward fibronectin was also inhibited by RGD
but not RGE peptides (Fig. 3B). However, RGD peptides did not
fully block migration of L1-B35 cells, suggesting the minor con-
tribution of an RGD-independent mechanism. As an example, L1
might increase 51 integrin affinity for the fibronectin synergy
sequence, or alternatively L1 might activate a non-RGD-binding
integrin, such as 41 integrin, which binds the Glu-Ile-Leu-Asp-
Val (EILDV) sequence in fibronectin. In any case, adhesion of
cells was not significantly altered by RGD peptides, because there
was no decrease in total cell number on the top and bottom sides
of the filters.
An RGD in the L1 Ig6 domain is required for
potentiating migration
There is only one RGD sequence in the Ig6 domain of human L1
(Hlavin and Lemmon, 1991). Conservative mutation of the L1
RGD to Lys-Gly-Glu (KGE) reduced L1-potentiated migration
of HEK293 cells toward fibronectin to the level of HEK293 cells
not expressing L1 (Fig. 4). This effect was highly specific for the
RGD3KGE mutation, because L1-potentiated migration was
not adversely affected by a number of different CRASH point
Figure 2. L1 potentiates migration of HEK293 cells through integrins.
Haptotactic migration of HEK293 (10,000 cells per chamber) expressing
no L1 or L1(RSLE) toward fibronectin was measured for 4 hr. Cells
were pretreated as follows: none (None), nonimmune mouse IgG (NIgG),
anti-L1 monoclonal antibody Neuro4 (Anti-L1), anti-integrin 5 antibody
(Anti-5), anti-integrin 1 antibody (Anti-1), a combination of antibod-
ies against 5 and 1 integrins (Anti-51), or anti-integrin v3
(Anti-v3) monoclonal antibody (each at 20 g/ml). *Statistically signif-
icant differences in means of treated and untreated (None) samples using
the t test ( p  0.05).
Figure 3. RGD peptides abrogate L1-potentiated migration toward fi-
bronectin. HEK293 (10,000 cells per chamber) (A) or B35 cells (20,000
cells/chamber) expressing no L1 or L1(RSLE) (B) were incubated with
or without hexapeptide GRGDS (RGD) or inactive GRGES (RGE)
control peptides (2 mM) for 1 hr on ice and then assayed for haptotactic
migration toward fibronectin or BSA for 4 hr. Each sample was assayed in
triplicate, and experiments were repeated at least twice with similar
results. *Statistically significant differences in means of treated and un-
treated (No Peptide) samples using the t test ( p  0.05).
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mutations in other extracellular domains of L1 (R184Q in Ig2,
H210Q in Ig2, E309K in Ig3, Y784C in FN2, Y1070C in FN5)
(Fig. 4). Each of these mutants is expressed at levels equivalent to
wild type on the surface of HEK293 cells and is able to recruit
ankyrin normally to the plasma membrane (Needham et al.,
2001). Surface expression of some of these (R184Q, E309K,
Y784C) has been reported to be impaired (29–72%) in Chinese
hamster ovary (CHO) cells (DeAngelis et al., 2002) and thus the
altered surface expression appears to be cell-type dependent. The
R184Q and E309K mutations are known to interfere with L1
binding to heterophilic partners F3/F11/contactin and axonin-1/
Tag-1 (DeAngelis et al., 1999); thus the ability of wild-type L1 to
stimulate migration to fibronectin was unlikely to be mediated
through these molecules. In addition, the R184Q mutation as well
as the H210Q mutation perturb homophilic L1–L1 binding
(DeAngelis et al., 1999) and neurite outgrowth on L1 substrates
(Zhao and Siu, 1996), suggesting that the mechanism of L1-
potentiated migration to extracellular matrix proteins also did not
involve homophilic L1–L1 interactions. These results indicated
that the RGD sequence in the Ig6 domain of L1 was a critical
determinant of L1-potentiated cell migration to extracellular
matrix.
Neuronal L1 enhances migration through dynamin I,
c-Src, PI3 kinase, and MAP kinase
The neuronal splice form L1(RSLE) is endocytosed rapidly by
clathrin and dynamin-mediated endocytosis required for MAP
kinase signaling (Kamiguchi et al., 1998; Schaefer et al., 1999;
Schmid et al., 2000), whereas the non-neuronal form lacking RSLE
is endocytosed more slowly by a clathrin-independent mechanism
(Long et al., 2001). Haptotactic migration of HEK293 cells toward
fibronectin was potentiated after 4 hr by L1(RSLE), which
binds the AP2/clathrin adapter (Kamiguchi et al., 1998), and not
by the non-neuronal form of L1 lacking RSLE (Fig. 4). Expres-
sion of the dominant negative dynamin I (K44A) mutant, which
impairs receptor-mediated endocytosis, abolished the migration-
potentiating effect of L1(RSLE) (Fig. 5). This mutant also
produced a small but significant inhibitory effect on migration of
HEK cells to fibronectin in accord with evidence that dynamin-
dependent internalization of 1 integrins plays a role in cell
motility (Ng et al., 1999; Pierini et al., 2000). These results
suggested that L1-potentiated migration to fibronectin in
HEK293 cells after 4 hr occurred through a mechanism involving
clathrin- and dynamin-mediated endocytosis. Cells expressing
L1(RSLE) might exhibit potentiated migration after longer
migration times because this form is internalized more slowly
(Long et al., 2001); however, HEK293 cells have a rapid rate of
migration that precluded examining this possibility.
The nonreceptor tyrosine kinase c-Src is required for endocy-
tosis of L1 (Schmid et al., 2000), regulation of neurite outgrowth
on L1 (Ignelzi et al., 1994), and L1-induced MAP kinase activa-
tion (Schmid et al., 2000). Expression of the dominant negative
Src (K295M) mutant in L1(RSLE)-transfected HEK293 cells
decreased L1-potentiated migration to the level of untransfected
cells (Fig. 5). To confirm the role of c-Src in L1-potentiated
haptotactic migration in neuronal cells, B35 neuroblastoma cells
stably expressing L1(RSLE) and parental B35 cells lacking L1
were treated with PP2, a pyrazolopyrimidine inhibitor selective
for Src family kinases, under conditions that inhibit Src in cell
culture (Hanke et al., 1996). PP2 substantially inhibited the hap-
totactic migration of L1(RSLE)-B35 cells to fibronectin but did
not significantly inhibit migration of parental B35 cells (Fig. 6).
PP3, an inactive structural analog, did not affect the migration of
either L1(RSLE)-expressing or parental B35 cells, and the
inhibitor solvent DMSO (0.05%) had no significant effect. PP2 did
not completely inhibit migration of L1-expressing cells, suggest-
ing that there was either an Src-independent component of L1-
potentiated migration or that sufficient levels of PP2 were not
sustained over the duration of the assay.
MAP kinase and PI3 kinase are phosphorylated and activated
during L1 endocytosis through Src (Schmid et al., 2000). To
determine whether MAP kinase was important for haptotactic
Figure 4. L1-potentiated migration to fibronectin requires RGD and
RSLE sequences in L1. HEK293 cells were transfected for transient
expression of L1(RSLE), L1(RSLE), or L1(RSLE) with
RGD3KGE or extracellular CRASH mutations. Cells were assayed for
haptotactic migration toward fibronectin for 4 hr. Each sample was as-
sayed in duplicate or triplicate, and experiments were repeated at least
twice with similar results. *Statistically significant differences in means of
L1 mutants compared with L1(RSLE) using the t test ( p  0.05).
Figure 5. L1-potentiated migration is regulated by dynamin-1 and c-Src.
HEK293 cells were transfected with or without human L1(RSLE) and
one of the following plasmids: pcDNA3 (Control ), dominant negative
dynamin-1(K44A) (DN-Dynamin), or dominant negative c-Src(K295M)
(DN-Src). Cells were assayed for haptotactic migration toward fibronectin
or random migration to BSA for 2 hr. Each sample was assayed in
triplicate and repeated at least twice with similar results. *Statistically
significant differences in means of mutant-expressing and control cells
using the t test ( p  0.05).
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cell migration to fibronectin, B35 cells and L1(RSLE)-B35 cells
were treated with an inhibitor (U0126) of the dual specificity
kinase MEK, which phosphorylates and activates MAP kinase.
The inhibitor was used under conditions that produce maximal
inhibition of L1-promoted neurite growth and phosphorylation of
the MAP kinases ERK1 and ERK2 in B35 cells (Schmid et al.,
2000). The MEK inhibitor effectively suppressed migration of
both parental and L1-expressing B35 cells to fibronectin, indicat-
ing that MAP kinase was required for haptotactic migration to
fibronectin (Fig. 6). To assess the involvement of PI3 kinase, B35
cells and L1(RSLE)-B35 cells were treated with the PI3 kinase
inhibitor LY294002 under conditions that inhibit ERK1,2 phos-
phorylation in L1-B35 cells (Schmid et al., 2000). Ly294002 sig-
nificantly inhibited migration of both L1-expressing and parental
B35 cells to fibronectin, indicating that PI3 kinase also played a
role in haptotactic migration to extracellular matrix proteins.
MAP kinase activation and haptotactic migration are
impaired by L1 CRASH mutations
Three known mutations in the intracellular domain of L1 occur-
ring in the CRASH syndrome were assessed for adverse effects
on potentiating migration to fibronectin. Established B35 cell
lines were studied that expressed L1(S1194L), L1(S1224L), or
L1(Y1229H) at levels equivalent to wild-type L1 in L1(RSLE)-
B35 cells (Needham et al., 2001). All three mutants displayed
reduced ability to potentiate haptotactic migration to fibronectin
(Fig. 7). Similar results were observed in HEK293 cells tran-
siently expressing these mutants (data not shown). Attachment of
B35 or HEK293 cells to the filters was unaffected by expression of
L1 mutant proteins, because the total number of cells on both
sides of the filters was the same for mutant and wild-type L1-
expressing cells after the migration assay.
To determine whether the intracellular L1 CRASH mutants
were coordinately impaired for intracellular signaling to MAP
kinase, ERK2 phosphorylation was assayed in B35 cells express-
ing L1(RSLE) or L1 CRASH mutants. L1 was clustered on the
B35 cell surface with complexes of Neuro4 monoclonal antibodies
against the L1 extracellular domain, followed by immunoprecipi-
tation and immunoblotting for dually phosphorylated, activated
ERK2 as described (Schmid et al., 2000). This antibody recog-
nizes all L1 mutants equivalently as shown by immunoblotting
and immunolabeling (Needham et al., 2001). L1(RSLE)-B35
cells displayed levels of ERK2 phosphorylation approximately
threefold greater than parental B35 cells as expected (Schaefer et
al., 1999; Schmid et al., 2000), whereas B35 cells expressing L1
mutants S1194L, S1224L, or Y1229H exhibited significantly lower
levels of ERK2 phosphorylation (Fig. 8). The neuronal L1 RSLE
sequence in the cytoplasmic domain was also required for max-
imal MAP kinase activation in B35 cells, as shown by the sub-
stantial reduction in ERK2 phosphorylation in B35 cells express-
ing L1(RSLE) (Fig. 8) in accord with studies using other cell
types (Schaefer et al., 1999). To address whether the RGD
sequence in the L1 Ig6 domain was required for MAP kinase
activation induced by L1 clustering, B35 neuroblastoma cells
expressing the RGD3KGE mutation were analyzed similarly for
ERK2 phosphorylation. Cells expressing the L1(KGE) mutant
displayed a significantly reduced level of ERK2 phosphorylation
compared with wild-type L1(RSLE) (Fig. 9). Thus effective
MAP kinase activation and potentiated migration required de-
terminants of the L1 cytoplasmic domain, including the RSLE
motif necessary for L1 internalization through the clathrin path-
way, and additionally the extracellular RGD sequence in the L1
Ig6 domain.
Endocytosis of L1 and 1 integrins
The results above raised the possibility that L1 might act by
stimulating the endocytosis of 1 integrins. To test this,
L1(RSLE)-transfected and nontransfected HEK293 cells were
treated with L1 antibody 6096 under conditions sufficient to
cluster cell surface L1 and also with the 1 integrin-activating
antibody MAB2000, and then internalization was followed by
Figure 6. Src kinase, MAP kinase, and PI3 kinase are required for
L1-potentiated migration of B35 cells. Migration of B35 cells expressing
no L1 or L1(RSLE) was measured toward fibronectin for 16 hr. Cells
were untreated or treated with 0.05% DMSO alone or with Src kinase
inhibitor PP2 (1 M), inactive analog PP3 (1 M), PI3 kinase inhibitor
Ly294002 (25 M), or MEK inhibitor UO126 (10 or 20 M). Each sample
was assayed in triplicate, and experiments were repeated at least twice
with similar results. *Statistically significant differences in means of
treated and untreated cells using the t test ( p  0.05).
Figure 7. CRASH mutations in the L1 cytoplasmic domain suppress
L1-potentiated migration to fibronectin. B35 cell lines stably expressing
no L1 (B35), wild-type L1(RSLE), or L1(RSLE) with point muta-
tions S1194L, S1224L, or Y1229H were assayed for haptotactic migration
to fibronectin for 24 hr. Each sample was assayed in triplicate, and
experiments were repeated at least twice with similar results. *Statisti-
cally significant differences in means compared with L1(RSLE) using
the t test ( p  0.05).
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double-label indirect immunofluorescence. As seen by confocal
microscopy, L1 and 1 integrins were initially present on the
surface of L1-transfected cells (Fig. 9A,B) (0 min). A similar
distribution of 1 integrin was seen in untransfected cells (Fig.
9D). In image overlays, L1 and 1 integrins appeared to represent
primarily distinct molecular populations on the cell surface (Fig.
9C). After 5 min of antibody treatment, 1 integrins and L1 were
observed in small cytoplasmic vesicles (Fig. 9E,F, arrows), which
were probably early endosomes as judged from their size, loca-
tion, and time of appearance (Ng et al., 1999). L1 and 1 integrins
did not colocalize to a major degree within these endocytic
vesicles (Fig. 9G). Interestingly, substantially more 1 integrin-
containing vesicles were seen after 5 min in L1-transfected cells
(Fig. 9E) compared with nontransfected cells (Fig. 9H). Image
analysis revealed that 2.5-fold more 1 integrin accumulated in
internalized vesicles in L1(RSLE)-expressing cells than in un-
transfected HEK cells (no L1) (Fig. 10). After 60 min, L1 anti-
body complexes accumulated in larger endocytotic vesicles with
the appearance of multivesicular bodies (Fig. 9J, long arrow) in
accord with previous results (Kamiguchi et al., 1998; Needham et
al., 2001). At this time 1 integrins were still present in the small
endocytic vesicles and few colocalized with L1 (Fig. 9 I,K). Non-
transfected cells displayed less prominent internalization of 1
integrin than L1 transfected cells at 60 min (Fig. 9L) or 40 min
(data not shown). These results were consistent with the inter-
pretation that L1 clustering induced an accumulation of 1 inte-
grins in early endocytic vesicles.
This increase was dependent on the RGD sequence in the L1
Ig6 domain, because clustering of the L1(KGE) mutant expressed
in HEK293 cells did not elicit enhanced 1 integrin accumulation
at 5 min of incubation (Fig. 9M), although the L1 mutant ap-
peared to be internalized (Fig. 9N). Image analysis revealed that
L1 (KGE)-expressing cells internalized approximately the same
amount of 1 integrin as untransfected HEK293 cells (no L1)
(Fig. 10). It should be noted that a physical association between L1
and 1 integrin was also not detected by co-immunoprecipitation
from 1% Triton X-100 extracts of L1(RSLE)-transfected
HEK293 cells plated on fibronectin with or without antibody-
induced L1 clustering or from extracts of postnatal day 7 mouse
cerebelli (data not shown).
L1 and 1 antibodies perturb neuronal migration in
acute cerebellar slices
To evaluate the significance of L1 and 1 integrins in neuronal
cell migration in a bioassay, we tested the ability of function
blocking L1 and 1 integrin antibodies to perturb migration of
cerebellar granule neurons in mouse cerebellar slice cultures. L1
is expressed on postmitotic premigratory and migrating cerebel-
lar granule neurons (Persohn and Schachner, 1987), and L1
antibodies have been reported to impede granule cell migration
in explants (Lindner et al., 1986; Chuong et al., 1987; Crossin et
al., 1990). Extracellular matrix proteins such as laminin, throm-
bospondin, and tenascin are also present in the developing cere-
bellum and participate in aspects of cell migration (O’Shea et al.,
1990; Husmann et al., 1992; Liesi et al., 1992; Fishman and
Hatten, 1993). To ask whether L1 and 1 integrins could coop-
erate in modulating granule cell migration under conditions re-
flective of an in vivo environment, mouse cerebellar neurons
generated on postnatal day 4 were pulse labeled with BrdU in vivo
as described (Anton et al., 1996). Labeled cerebella were sec-
tioned coronally into 200 m slices and incubated in culture for
21 hr in the presence and absence of L1 and 1 integrin antibod-
ies. After 21 hr the extent of radial migration of BrdU-labeled
neurons from the EGL into the IGL was assessed after fixation by
immunofluorescence staining with BrdU antibodies. At time 0,
labeled cells were present almost exclusively in the EGL (Fig.
Figure 8. MAP kinase activation is im-
paired by L1 CRASH mutations. Parental
B35 cells were cotransfected for transient
expression of HA-tagged ERK2 and plas-
mids encoding L1( or RSLE) or indi-
cated L1 mutants. Cells were stimulated for
10 min with NIgG or L1 monoclonal anti-
body Neuro4 complexed with F(ab)2 frag-
ments of anti-mouse IgG (Fc-specific). HA-
tagged ERK2 was immunoprecipitated
with anti-HA antibody and blotted with
anti-Active MAPK antibodies ( p ERK2),
and then the amount of immunoprecipi-
tated ERK2 protein was analyzed by strip-
ping and reprobing blots with ERK2
antibodies (ERK2) as shown in a represen-
tative experiment in the panels below.
Densitometric scanning determined the
amount of ERK2 phosphorylation relative
to ERK2 protein in L1 antibody-treated
and NIgG-treated cells. Results of multiple
experiments were averaged to obtain the
mean values with SEM shown in the panel
above. ERK2 phosphorylation is expressed
relative to basal levels of ERK2 phosphor-
ylation in nonimmune IgG-treated B35
cells (NIg). *Statistically significant differ-
ences in the mean ERK2 phosphorylation
of L1 mutant-expressing B35 cells com-
pared with L1(RSLE)-B35 cells were
evaluated by the t test ( p  0.02).
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Figure 9. Antibody-induced endocytosis of L1 and 1 integrins in L1-expressing HEK cells. HEK293 cells were transfected for transient expression
with L1(RSLE) (A–C, E–G, I–K ) or mutant L1(KGE) ( M–O) plasmids. Confocal microscopy images of cells are labeled green for 1 integrin (A, E,
I, M ), red for wild-type or mutant L1 (B, F, G), and yellow for colocalized 1 integrin and L1 (C, G, K, O). Nontransfected cells were labeled green for
1 integrin alone (D, H, L). Live HEK cells were incubated with antibodies against L1 and 1 integrin for 0 min (A–D), 5 min (E–H, M–O), or 60 min
( I–L). After 5 min, increased internal staining of 1 integrins was seen in L1-transfected cells (E, arrowheads) compared with nontransfected cells (H ).
Long arrow in J indicated larger endocytotic vesicles of wild-type L1 resembling multivesicular bodies. L1(KGE) mutant cells (M ) did not show increased
1 integrin internalization after 5 min. Images show representative cells from multiple experiments. Scale bars, 10 m.
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11A). After 21 hr, many labeled cells had migrated into the IGL
with some remaining in the EGL (Fig. 11B). Nonimmune IgG
had no effect on granule cell migration (Fig. 11C). In the presence
of either polyclonal L1 antibodies (Fig. 11D) or monoclonal 1
integrin antibodies (E), there was little visible retardation in
granule cell migration. However, in the presence of both L1 and
1 integrin antibodies, migration was strikingly inhibited, as
manifested in an accumulation of labeled neurons in the EGL
(Fig. 11F). Cell migration was not inhibited completely, because
labeled cells were also present in the top part of the IGL,
indicating the involvement of other factors. Quantitative evalua-
tion of the effect of antibodies on migration of labeled neurons
was made by measurement of the migration index; i.e., the radial
distance (perpendicular to the pial surface) that BrdU-labeled
granule cells migrated relative to the width of the cerebellar
cortex in the same region. L1 or 1 integrin antibodies alone
produced a small but significant decrease in the migration index.
The inhibition of migration by our L1 antibody (17%) after 21 hr
in vitro was in general accord with the inhibition (33%) reported
by Lindner et al. (1986) for slices from P10 mice using a different
L1 antibody after 3 d in vitro. A combination of the two antibodies
decreased the migration index to a greater than additive extent
(Table 1). The percentage of BrdU-labeled cells in the EGL was
also measured and was found to increase to a greater extent in the
presence of both antibodies compared with either antibody alone
(Table 1). By this measurement the 1 integrin antibody but not
the L1 antibody significantly reduced migration when used alone.
Differences in age of mice, antibodies, labeling, and culture con-
ditions may have contributed to the smaller inhibition of migra-
tion produced by L1 antibodies in our experiment compared with
Lindner et al. (1983). The results support a potential role for L1
and 1 integrins in coordinate regulation of radial migration of
cerebellar granule cells.
DISCUSSION
This study describes a novel function for L1 as a potentiator of
neuronal cell migration toward extracellular matrix proteins
through 1 integrins by a MAP kinase signaling pathway depen-
dent on receptor-mediated endocytosis. L1 potentiated haptotac-
tic migration through the fibronectin-specific integrin 51 in
HEK293 cells but appeared capable of activating other integrin
subclasses, because migration of B35 neuroblastoma cells to lami-
nin and vitronectin was also stimulated by L1. Potentiated migra-
tion depended on determinants of L1 endocytosis: dynamin I,
c-Src, and the AP2/clathrin binding sequence (RSLE) in the
neuronal form of L1. Determinants within the cytoplasmic do-
main of L1 that are mutated in the CRASH syndrome and the
RGD sequence in the extracellular Ig6 domain of L1 were essen-
tial for potentiating cell migration. Surprisingly, clustering of cell
surface L1 caused enhanced 1 integrin accumulation into endo-
cytic vesicles in addition to L1 internalization. Results were
consistent with a model in which L1 potentiated neuronal cell
migration toward extracellular matrix proteins through L1 and 1
integrin endocytosis leading to MAP kinase activation. Function-
blocking L1 and 1 integrin antibodies cooperatively retarded the
migration of granule neurons in early postnatal mouse cerebellar
slices, underscoring the potential for a functional L1 integrin
interaction in neuronal migration in vivo.
Several lines of evidence support the interpretation that poten-
tiation of integrin-mediated haptotactic migration by L1 derived
from its ability to activate MAP kinase through endocytosis of
L1. (1) Dominant negative dynamin I (K44A), which suppresses
L1 endocytosis and MAP kinase activation (Schaefer et al., 1999;
Schmid et al., 2000), inhibited L1-potentiated migration to fi-
bronectin. (2) The L1 RSLE sequence, which mediates clathrin-
dependent rapid L1 endocytosis (Schaefer et al., 1999; Long et
al., 2001), was required for L1-potentiated migration as well as
MAP kinase activation. Because the ERK inhibitor PD98059
does not block L1 internalization, MAP kinase activation occurs
subsequent to L1 endocytosis (Schmid et al., 2000). Because the
L1(-RSLE) form recycles more slowly than L1(RSLE), it re-
mains to be determined whether this form would stimulate mi-
gration and MAP kinase activity at longer times than were
evaluated in our assays. (3) Inhibition of c-Src kinase by PP2 or
the kinase-inactive Src (K295M) mutant blocked L1-potentiated
migration. c-Src is required for dynamin-mediated internalization
of L1 (Schmid et al., 2000) and other receptors (Carpenter, 2000).
Interestingly, c-Src can phosphorylate tyrosine residues in com-
ponents of the endocytic machinery, because 2 adrenergic stim-
ulation causes c-Src-induced tyrosine phosphorylation of dy-
namin (Ahn et al., 1999; Luttrell et al., 1999), and epidermal
growth factor stimulation induces c-Src-induced tyrosine phos-
phorylation and membrane recruitment of clathrin (Wilde et al.,
1999).
L1-potentiated migration and MAP kinase activation may also
depend on its ability to stimulate the internalization of 1 inte-
grins as observed in this study. One model consistent with all of
the evidence is that transient association of L1 with 1 integrin
through the L1 RGD sequence induces endocytosis of both L1
and 1 integrins, leading to activation of MAP kinase through 1
integrin signaling to potentiate migration toward extracellular
matrix proteins. In accord with this model, mutation of the L1
RGD sequence coordinately abolished its ability to stimulate the
accumulation of 1 integrin into endocytic vesicles and to acti-
vate MAP kinase. Furthermore, the time of maximal ERK phos-
phorylation induced by L1 (10 min) (Schmid et al., 2000) closely
followed the time of maximal 1 integrin accumulation into
endocytic vesicles (5 min). 1 integrins have been shown to
internalize with similar kinetics into early endosomes in non-
neuronal cells by a dynamin-dependent pathway (Ng et al., 1999).
The possibility that L1 signals to MAP kinase through 1 inte-
grins is consistent with the common intermediates shared by L1
Figure 10. Mean fluorescent pixel density of internalized 1 integrin in
confocal micrographs from experiments of Figure 9. After 5 min at 37°C
there was a statistically significant increase in internalized 1 integrins in
L1(RSLE)-HEK293 cells compared with HEK293 cells not expressing
L1 () and a decrease in internalized 1 integrins in L1(KGE)-expressing
cells compared with L1(RSLE)-HEK293 cells (**) by the t test (one-
tailed; p  0.05).
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Figure 11. Effect of L1 and 1 integrin antibodies on migration of newly generated BrdU-labeled neurons in cerebellar slice cultures. BrdU-labeled cell
distribution in postnatal day 4 mouse cerebellar slices after 0 hr in culture (A), after 21 hr in culture (B), after 21 hr in culture with nonimmune IgG
(C), after 21 hr in culture with L1 polyclonal antibody 6096 (D), after 21 hr in culture with 1 integrin monoclonal antibody CD29 (E), and after 21
hr in culture with both L1 antibody 6096 and 1 integrin antibody CD29 (F). At 0 hr, BrdU-labeled cells were restricted primarily to the EGL (A). In
the next 21 hr, newly generated BrdU-positive neurons migrated into the IGL under control conditions (B) or in the presence of nonimmune IgG (C).
In the presence of both L1 and 1 integrin antibodies (F), migration was impeded, and neurons did not migrate as far as neurons in the presence of only
L1 antibody (D) or 1 integrin antibody (E). EGL, External granular layer; ML, molecular layer; IGL, internal granular layer. The borders of the
Purkinje cell layer and ML/IGL were indistinct and thus were not delineated in this figure. Scale bar (shown in F for A–F ), 50 m.
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and early integrin signaling pathways (Src, PI3 kinase, Rac1,
Vav-2, ERK; see introductory remarks). Indeed PI3 kinase was
shown here to be required for haptotactic migration of B35 cells
to fibronectin. PI3 kinase may contribute to migration through its
ability to influence integrin endocytosis or recycling (Siddhanta
et al., 1998; Ng et al., 1999), because its product PI-3,4,5 phos-
phate can bind the plextrin homology domain of dynamin I and
stimulate dynamin GTPase activity in vitro (Barylko et al., 1998);
however, its exact function in haptotactic migration has not been
determined.
L1 also potentiated migration of B35 cells toward laminin,
which can bind in a non-RGD manner to certain integrins such as
61. An interesting possibility is that interactions between L1
and an RGD binding integrin might stimulate migration by
inside-out signaling to increase the affinity of non-RGD binding
integrins such as 61 for extracellular matrix. Such cross-talk
among integrin subclasses to increase integrin affinity is estab-
lished (Simon et al., 1997; Blystone et al., 1999) and can be
mediated by signaling from Ig-like cell adhesion molecules such
as PECAM (Chiba et al., 1999). Alternatively, L1 may regulate
non-RGD-binding integrins through its ability to interact with
integrins through its third fibronectin III domain (Silletti et al.,
2000) or through interaction with other cell surface molecules
such as the tetraspan cell surface molecule CD9, which can
enhance laminin-induced cell migration and neurite growth
through 61 integrin (Schmidt et al., 1996).
Current and previous findings do not preclude a mechanism in
which internalization of only L1 and not 1 integrins is the
critical factor in MAP kinase activation. Nonetheless 1 integrins
are clearly required for L1-potentiated migration as shown by
antibody perturbation experiments, but they could perform a
function other than signaling to MAP kinase. For example,
integrin endocytosis at the rear of cells may facilitate detachment
from the substrate necessary for forward migration, and together
with integrin recycling to the leading edge, endocytosis may help
establish an adhesive gradient needed for directional cell motility
(Bretscher, 1996; Lauffenburger and Horwitz, 1996; Condic and
Letourneau, 1997).
There is increasing evidence that signaling to MAP kinase can
occur from endosomal compartments (Ceresa and Schmid, 2000).
Elevated levels of internalized L1 or 1 integrins could prolong
signaling from endocytic compartments or place receptor com-
plexes in an appropriate cellular location to interact with down-
stream signaling molecules necessary for stimulating motility.
The substrates of MAP kinase important for L1-potentiated
haptotactic cell migration have not been identified but might
include cytoplasmic targets such as myosin light chain kinase, the
phosphorylation of which by ERK1,2 has been shown to be
required for collagen-dependent FG carcinoma cell motility
(Klemke et al., 1997), or nuclear transcription factors modulating
expression of genes important for cell motility such as those
encoding cytoskeletal proteins.
The RGD sequence in the L1 Ig6 domain was necessary for
potentiating haptotactic migration to fibronectin through 51
integrin, for stimulating 1 integrin accumulation in endocytic
vesicles, and for MAP kinase activation. The L1 RGD sequence
may directly interact with RGD-binding integrins either in cis or
trans, or it may simply stabilize a conformation necessary for the
signaling properties of L1. However, structural modeling predicts
that the L1 RGD sequence is located at the molecular surface
within a  turn, where it would be available for binding to
integrins (Drescher et al., 1996). Because we did not observe
colocalization of L1(RSLE) and 1 integrins in internalized
vesicles and did not detect a stable association between these
proteins by co-immunoprecipitation from transfected HEK293
cells or cerebellar extracts, such an association within the plasma
membrane might be transient or low in affinity. A cis-interaction
of the L1 and integrins 51, v3, and 91 mediating adhesion
in M21 melanoma cells that requires two dibasic sequences in the
third fibronectin III domain of L1 but could also involve the RGD
sequence has been described previously (Silletti et al., 2000). The
third fibronectin III domain was shown to be critical for neurite
outgrowth by cerebellar neurons in vitro (Stallcup, 2000). A po-
tential cis-interaction between L1 and integrins was implicated
previously in neurite growth of sensory neurons (Felsenfeld et al.,
1994) and PC12 cells (Yip and Siu, 2001). Through its RGD
sequence, L1 has also been shown to interact functionally, al-
though not physically, with several RGD-binding integrins (51,
v1, 41, v3, and IIb3) to mediate adhesion and neurite
outgrowth on L1 substrates (Moos et al., 1988; Ruppert et al.,
1995; Ebeling et al., 1996; Montgomery et al., 1996; Felding-
Habermann et al., 1997; Yip et al., 1998). In addition to enhancing
1 integrin internalization, potential binding of the L1-RGD
sequence to integrins might have the effect of increasing integrin
affinity for ligands, inasmuch as low concentrations of RGD
peptides superactivate integrin affinity for RGD-containing li-
gands (Legler et al., 2001).
While our studies were in progress, it was reported that ectodo-
main cleavage of L1 by ADAMs (A Disintegrin and Metallopro-
teinase) can promote migration of transfected CHO cells through
v5 integrin independent of the L1 cytoplasmic domain
(Mechtersheimer et al., 2001). Our experiments do not rule out
an involvement of metalloprotease cleavage of L1 in the mecha-
nism of haptotoactic migration. However, in our studies with B35
neuroblastoma cells and HEK293 cells, the cytoplasmic domain
of L1 plays an essential role in stimulating cell migration by
providing linkage to AP2/clathrin necessary for signaling and
perhaps also to the actin cytoskeleton through ankyrin as shown
by impairment of potentiated migration by particular CRASH
mutations in the L1 cytoplasmic domain.
Three mutations in the intracellular domain of L1 (S1194L,
S1224L, Y1229H) associated with the CRASH syndrome coordi-
nately impaired L1-potentiated haptotactic migration and MAP
kinase activation. Each of these mutants is capable of antibody-
induced internalization (Needham et al., 2001); thus their re-
duced capacity to potentiate haptotactic migration cannot be
ascribed to defective L1 internalization. Instead these L1 mutants
Table 1. Effect of L1 and 1 integrins on migration of BrdU-labeled
neurons in P4 mouse cerebellar slicesa
Treatment
Migration index (relative





None (0 hr) 0.18  0.01 94
None (21 hr) 0.59  0.03 11
Nonimmune IgG (21 hr) 0.54  0.02 6
L1 antibody (21 hr) 0.49  0.02* 7
1 integrin antibody (21 hr) 0.44  0.02* 14*
L1  1 integrin antibodies
(21 hr) 0.34  0.02* 27*
*Significantly different compared with nonimmune IgG control (21 hr) by the t test
(one-tailed; p  0.05).
aSee Materials and Methods for assay details.
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might be compromised in their ability to associate with critical
intracellular components important for cytoskeletal association.
In particular the L1(S1224L) and L1(Y1229H) mutants fail to
recruit the actin adapter protein ankyrin in cellular assays (Need-
ham et al., 2001). On the other hand, the L1(S1194L) mutant
recruits ankyrin normally (Needham et al., 2001), but it may
interfere with the function of juxtamembrane residues in the L1
cytoplasmic domain that have been shown to mediate association
with the actin cytoskeleton through a molecule other than
ankyrin (Dahlin-Huppe et al., 1997). The inabilities of the
L1(S1194L) mutation to potentiate haptotactic migration and to
activate MAP kinase represent the first defective cellular re-
sponses to be reported for this CRASH mutation. Because ex-
tracellular CRASH mutants (R184Q, H210Q, E309K, Y784C,
and Y1070C) potentiated migration of HEK293 cells normally,
impaired integrin-mediated functions would not appear to con-
tribute to the pathology associated with these mutations.
The capacity of L1 to potentiate haptotactic migration toward
extracellular matrix proteins through integrins in these in vitro
studies may reflect a physiological role for L1 in integrin-
dependent migration or guidance of neuronal precursors during
nervous system development. Neuronal migration and axon guid-
ance are influenced by extracellular matrix proteins in the emby-
ronic brain (Reichardt and Tomaselli, 1991; Liesi et al., 1992;
Sheppard et al., 1995), and integrin knock-out mice reveal critical
functions for 1 integrins in neuronal migration and laminar
organization of the cerebral cortex (Anton et al., 1999; Dulabon
et al., 2000). The reduction of cerebellar neuron migration in
acute slice preparations by a combination of function-blocking L1
and 1 integrin antibodies may reflect alterations in glial-
dependent or glial-independent stages of neuronal migration,
which differ in mode, rate, and mechanism (Komuro and Rakic,
1998; Komuro et al., 2001). It should be noted that the combined
inhibition by L1 and 1 integrin antibodies, although greater than
additive, did not completely prevent neuronal migration and thus
may not reflect a cooperative mechanism for cerebellar granule
cell migration in vivo. Clearly not all cerebellar neurons were
affected by the antibodies, and the conditions used for acute slice
preparations could affect neuronal migration mechanisms. None-
theless, the reduction in migration of labeled neurons through the
IGL in the presence of L1 antibodies alone was in general accord
with other studies using L1 antibodies to perturb granule cell
migration in mouse cerebellar slices (Lindner et al., 1983, 1986)
and Ng-CAM antibodies in chick cerebellar slices (Chuong et al.,
1987; Crossin et al., 1990). Although 1 integrin antibodies alone
produced a small inhibition of granule cell migration in our
system, greater inhibition was seen in combination with L1 anti-
bodies, predicting that the relatively unimpaired migration of
cerebellar neurons in conditional 1 integrin knock-out mice
(Graus-Porta et al., 2001) might be more strongly perturbed in
L1–1 integrin double mutants. Other L1 family members may
share the ability to promote cell migration or axon growth
through integrins. Indeed, NrCAM cooperates with 1 integrins
in retinal ganglion cells to promote fibronectin-induced neurite
outgrowth (Treubert and Brummendorf, 1998). In conjunction
with 1 integrins, L1 may contribute to normal neurodevelop-
mental processes, whereas mutation of critical residues in the L1
cytoplasmic domain may give rise to abnormal aspects of neuro-
nal migration that result in pathological features of brain devel-
opment or mental function in the CRASH syndrome.
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